Physician profile
William Decarbo
NPI 1851416606
$3,472,573.06
in general payments reported to CMS, 2019-2025
15 companies · $849K in 2025
The $849K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $128K · 2021: $226K · 2022: $491K · 2023: $782K · 2024: $925K · 2025: $849K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.7M · Consulting Fee: $815K · Travel and Lodging: $51K · Food and Beverage: $17K · Education: $424 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,672,338.85 |
| Consulting Fee | $815,242.75 |
| Travel and Lodging | $51,114.08 |
| Food and Beverage | $17,110.63 |
| Education | $423.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,426,304.55 | 2019-2025 | |
| Smith+Nephew, INC. | $45,179.54 | 2019-2023 | Evos Mini, Evos |
| Stryker Corporation | $371.21 | 2022-2024 | 7 X 23mm Citrelock Implant, Invision, Ortholoc 2 Lapifuse |
| Zimmer Biomet Holdings, INC. | $183.78 | 2020 | |
| Medline Industries Lp | $175.00 | 2020-2021 | |
| In2bones USA, LLC | $144.09 | 2021 | |
| Ethicon US, LLC | $50.03 | 2021-2022 | |
| Mid-Atlantic Surgical Systems, LLC | $43.43 | 2019-2022 | |
| Horizon Therapeutics Plc | $36.34 | 2020-2023 | Krystexxa |
| 4web, INC. | $22.31 | 2019 | |
| Bioventus LLC | $19.37 | 2023 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $19.26 | 2024 | Eterna |
| Vertex Pharmaceuticals Incorporated | $14.20 | 2025 | |
| Orthofix Medical, INC. | $6.62 | 2020 | |
| Amniox Medical, INC. | $3.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Decarbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.